GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adagio Medical Holdings Inc (NAS:ADGM) » Definitions » Net Income From Continuing Operations

ADGM (Adagio Medical Holdings) Net Income From Continuing Operations : $-7.71 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Adagio Medical Holdings Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Adagio Medical Holdings's net income from continuing operations for the three months ended in Mar. 2025 was $-7.71 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was $-7.71 Mil.


Adagio Medical Holdings Net Income From Continuing Operations Historical Data

The historical data trend for Adagio Medical Holdings's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagio Medical Holdings Net Income From Continuing Operations Chart

Adagio Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
-19.94 -23.67 -38.15 -

Adagio Medical Holdings Quarterly Data
Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only -10.18 -8.02 - - -7.71

Adagio Medical Holdings Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adagio Medical Holdings Business Description

Traded in Other Exchanges
N/A
Address
26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.